Shares of other companies:
April 24, 2024 Google’s Third Cookie Phaseout Delay Amid Regulatory Hurdles
April 19, 2024 Bitcoin Halving: Catalyst for New Price Heights?
Tesla Q1: Model 2 Could Be Their Model T
April 25, 2024
Tesla Is An AI Company That The Market Won’t Reward For Now
April 24, 2024
Amazon: The Margin Train Is Gaining Speed
April 24, 2024
April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?
Selling a business can be a momentous decision filled with many considerations and uncertainties. As an entrepreneur, this also symbolizes your years of…
April 12, 2024 Improve Your Financial Status: A How-To Guide
Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade
Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5
One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…
INO Stock News and Mentions of Inovio Pharmaceuticals, Inc. Stocktwits
Updated: April 26, 2024 (09:55)
Sector: Healthcare
Welcome to PandaPulse, innovative analytical stock market observer, where the latest news and stocktwits meets in-depth investor relations insights. Dive into our real-time sentiment analysis to gauge the mood of the markets and arm yourself with key information that resonates with both savvy investors and casual traders.
We meticulously analyze the sentiment trend in each article for the last 60 days where Inovio Pharmaceuticals Company is mentioned. We assess its relevance and importance to carry out an overall sentiment valuation of Inovio Pharmaceuticals, Inc. (INO).
You can view the trend designation for each individual article below. We use this data to compile indicators into one comprehensive sentiment value, which represents the current information agenda about the Inovio Pharmaceuticals stocks.
Please wait, while the data is preparing...
General evaluation of the current information agenda's sentiments
Agenda Trend
Analyzed articles
News and Mentions of Inovio Pharmaceuticals, Inc. (INO)
April 16, 2024 (12:14) / "Benzinga" (by Avi Kapoor)
Why Macatawa Bank Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket - Macatawa Bank ( NASDAQ:MCBC )
Shares of Macatawa Bank Corporation MCBC rose sharply in today's pre-market trading after Wintrust Financial Corporation WFTC and Macatawa Bank announced that they have entered into a definitive merger agreement for Wintrust to acquire Macatawa in an all-stock transaction.
In Article Trend: Neutral
April 16, 2024 (10:53) / "Benzinga" (by Avi Kapoor)
Live Nation Entertainment, Groupon And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Groupon ( NASDAQ:GRPN ) , Live Nation Entertainment ( NYSE:LYV )
U.S. stock futures were mixed this morning, with the Dow futures gaining around 100 points on Tuesday. Shares of Live Nation Entertainment, Inc. LYV fell sharply in today's pre-market trading following a report indicating the Justice Department will file an antitrust lawsuit against the company.
In Article Trend: Neutral
April 8, 2024 (21:41) / "PR Newswire" (by DelveInsight Business Research)
HPV16+ Cancer Treatment Market is Expected to Showcase Significant Growth by 2034, Assesses DelveInsight | Key Companies in the Market - Nykode Therapeutics, Roche, ISA Pharmaceuticals, Regeneron, Transgene
HPV16+ Cancer Treatment Market is Expected to Showcase Significant Growth by 2034, Assesses DelveInsight | Key ... PR ...
In Article Trend: Neutral
April 6, 2024 (10:26) / "Stocknews.com" (by Defense World Staff)
Inovio Pharmaceuticals ( NASDAQ:INO ) Downgraded by StockNews.com
StockNews.com cut shares of Inovio Pharmaceuticals ( NASDAQ:INO - Free Report ) from a hold rating to a sell rating in a report published on Friday morning. A number of other equities research analysts have also commented on the stock.
In Article Trend: Bullish
March 11, 2024 (13:45) / "Benzinga" (by Benzinga Insights)
Peering Into Inovio Pharmaceuticals's Recent Short Interest - Inovio Pharmaceuticals ( NASDAQ:INO )
Inovio Pharmaceuticals's INO short percent of float has risen 22.31% since its last report. The company recently reported that it has 1.74 million shares sold short, which is 7.73% of all regular shares that are available for trading.
In Article Trend: Somewhat-Bullish
March 10, 2024 (08:36) / "Stocknews.com" (by ABMN Staff)
Inovio Pharmaceuticals ( NASDAQ:INO ) Rating Increased to Hold at StockNews.com
Inovio Pharmaceuticals ( NASDAQ:INO ) Rating Increased to Hold at ...
In Article Trend: Bullish
March 10, 2024 (08:34) / "Stocknews.com" (by Defense World Staff)
Inovio Pharmaceuticals ( NASDAQ:INO ) Upgraded by StockNews.com to Hold
Inovio Pharmaceuticals ( NASDAQ:INO - Get Free Report ) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating in a research report issued to clients and investors on Friday. INO has been the topic of several other research reports.
In Article Trend: Somewhat-Bullish
March 8, 2024 (14:55) / "Zacks Commentary" (by Zacks Equity Research)
Does Inovio ( INO ) Have the Potential to Rally 122.92% as Wall Street Analysts Expect?
The consensus price target hints at a 122.9% upside potential for Inovio (INO). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
In Article Trend: Somewhat-Bullish
March 8, 2024 (13:55) / "Zacks Commentary" (by Zacks Equity Research)
Does Inovio ( INO ) Have the Potential to Rally 122.92% as Wall Street Analysts Expect?
The consensus price target hints at a 122.9% upside potential for Inovio (INO). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
In Article Trend: Somewhat-Bullish
March 7, 2024 (02:18) / "Benzinga" (by Benzinga Neuro)
VSCO, INO, AVGO, APM, TSLA: Top 5 Trending Stocks Today - Broadcom ( NASDAQ:AVGO ) , Aptorum Gr ( NASDAQ:APM )
On Wednesday, U.S. indices closed positively as the Dow Jones Industrial Average edged up by 0.2% to reach 38,661.05. Meanwhile, the S&P 500 experienced a slight rise of 0.5%, settling at 5,104.76, whereas the Nasdaq rose by 0.6% to hit 16,031.54.
In Article Trend: Neutral
February 28, 2024 (23:10) / "Zacks Commentary" (by Zacks Equity Research)
CymaBay Therapeutics Inc. ( CBAY ) Reports Q4 Loss, Misses Revenue Estimates
CymaBay Therapeutics Inc. (CBAY) delivered earnings and revenue surprises of -9.38% and 85.75%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
In Article Trend: Neutral
Related stocks from Healthcare sector
This website uses cookies to ensure you get the best experience on our website